Zhejiang Xinguang Pharmaceutical Co., Ltd.

SZSE:300519 Stock Report

Market Cap: CN¥2.3b

Zhejiang Xinguang Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

Zhejiang Xinguang Pharmaceutical has a total shareholder equity of CN¥817.9M and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥892.5M and CN¥74.5M respectively. Zhejiang Xinguang Pharmaceutical's EBIT is CN¥30.3M making its interest coverage ratio -2.1. It has cash and short-term investments of CN¥669.6M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-2.1x
CashCN¥669.61m
EquityCN¥817.92m
Total liabilitiesCN¥74.53m
Total assetsCN¥892.45m

Recent financial health updates

No updates

Recent updates

Earnings Not Telling The Story For Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519) After Shares Rise 38%

Oct 18
Earnings Not Telling The Story For Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519) After Shares Rise 38%

Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

May 26
Zhejiang Xinguang Pharmaceutical (SZSE:300519) Has Announced That Its Dividend Will Be Reduced To CN¥0.40

Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Apr 16
Calculating The Intrinsic Value Of Zhejiang Xinguang Pharmaceutical Co., Ltd. (SZSE:300519)

Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement

Feb 26
Zhejiang Xinguang Pharmaceutical Co., Ltd.'s (SZSE:300519) Low P/E No Reason For Excitement

Financial Position Analysis

Short Term Liabilities: 300519's short term assets (CN¥753.7M) exceed its short term liabilities (CN¥65.5M).

Long Term Liabilities: 300519's short term assets (CN¥753.7M) exceed its long term liabilities (CN¥9.0M).


Debt to Equity History and Analysis

Debt Level: 300519 is debt free.

Reducing Debt: 300519 had no debt 5 years ago.

Debt Coverage: 300519 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 300519 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies